Task: Answer Verification
Input (English): Question: Does erythropoietin priming improve the vasculogenic potential of G-CSF mobilized human peripheral blood mononuclear cells?
Answer: Brief ex vivo EPO-priming is a novel method to augment the vasculogenic potential of human (mob)PBMCs, which would help to achieve better results after intracoronary infusion in myocardial infarction patients.
Output (English): yes